At 5.5% CAGR, Middle East & Africa Blood Collection Devices Market is Projected to be Worth US$ 409.00 Million by 2030, says Business Market Insights

According to Business Market Insights research, the Middle East & Africa blood collection devices market was valued at US$ 266.85 million in 2022 and is expected to reach US$ 409.00 million by 2030, registering a CAGR of 5.5% from 2022 to 2030. Increase in prevalence of cancer worldwide and surge in demand for minimally invasive diagnostic tests are among the critical factor attributed to the Middle East & Africa blood collection devices market expansion.

Healthcare facilities across the globe are observing a substantial increase in the prevalence of cancer. According to the National Cancer Institute, cancer is increasingly becoming a global health issue. In 2020, there were 19.3 million new cancer cases, resulting in approximately 10 million cancer-related deaths worldwide. The World Health Organization estimated that, by 2040, there could be 28.9 million new cancer cases globally and ∼16.2 million cancer-related deaths yearly. The most common method for a blood test for cancer is a liquid biopsy; this method is used for diagnosing non-small cell lung cancer (NSCLC) and screening other types of cancers such as breast, colorectal, prostate, gastrointestinal, and ovarian. As a result, blood collection tubes contribute to the organization's strategy for the early detection of cancer, allowing for quick treatment and enhancing cancer patients' survival rates. Thus, the increasing prevalence of cancer drives the Middle East & Africa blood collection devices market.

On the contrary, risk associated with needlestick injuries hampers the growth of Middle East & Africa blood collection devices market.

Based on product type, the Middle East & Africa blood collection devices market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held 33.0% share of Middle East & Africa blood collection devices market in 2022, amassing US$ 88.00 million. It is projected to garner US$ 142.93 million by 2030 to expand at 6.2% CAGR during 2022–2030.

In terms of methods, the Middle East & Africa blood collection devices market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held 83.4% share of Middle East & Africa blood collection devices market in 2022, amassing US$ 222.52 million. It is projected to garner US$ 338.03 million by 2030 to expand at 5.4% CAGR during 2022–2030.

By end user, the Middle East & Africa blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held 58.4% share of Middle East & Africa blood collection devices market in 2022, amassing US$ 155.72 million. It is projected to garner US$ 241.44 million by 2030 to expand at 5.6% CAGR during 2022–2030.

Based on country, the Middle East & Africa blood collection devices market has been categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 35.8% share of Middle East & Africa blood collection devices market in 2022. It was assessed at US$ 100.11 million in 2022 and is likely to hit US$ 141.59 million by 2030, exhibiting a CAGR of 5.0% during 2022–2030.

Key players operating in the Middle East & Africa blood collection devices market are Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, and Greiner Bio One International GmBH, among others.

• In May 2022, Babson Diagnostics a science-first, health care technology company and BD a leading global medical technology company, today announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing.
• In May 2020, Greiner AG (Greiner Bio-One) expanded its business operations in Indonesia. The company has established its regional business operation units, such as manufacturing facilities. This helps the company to develop its business and get a stronghold over the respective regional markets.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com